Global Antacids Market will reach US$ 10.50 Billion in 2027. Industry Trends By Product, Application, End User, Impact of Inflation, Company Analysis, Global Forecast 2023-2027
Global Antacids Market Size
Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence of gastrointestinal disorders as well as improved lifestyle, and increased access to health care, which speaks volumes of the global need for effective, and easy to use antacids.
Global Antacids Market Definition
Most antacids work by breaking down the acid found in the stomach in order to help with cases of heartburn, indigestion and acid reflux. They include some required materials like aluminum hydroxide, magnesium hydroxide, calcium carbonate, sodium bicarbonate. Antacids have the capability to counter acidic stomach through a process of making the stomach pH level higher. This assists to reduce pain that is resultant from high levels of gastric acid secretion in the stomach which may culminate to diseases like GERD and peptic ulcer.Common medicines that are used to treat the symptoms that are associated with heartburn and that give a temporary relief include antacids. They are widely sold within the counter markets, and are available in form of tablets, liquids, and chewable tablets. Apart from the treatment of other disorders of the acid type, antacids may be used to suppress signs of gastritis and contribute to the improvement of the mucosal layer of the stomach. They are rather useful for short-term therapeutic purposes and usually cannot be taken in the long term while treating chronic acid-related diseases when other medicines may be advised by the doctor.
Driving Forces for the Antacids Market
Rising Prevalence of Gastrointestinal Disorders
An increase in the prevalence of gastrointestinal diseases such as acid reflux, GERD, and peptic ulcers is another factor that affects the demand for antacids. Therefore, modern development affects the augmentation of these pathologies due to the improper diet, frequent consumption of fast food, irregular food times, and increased levels of stress. As more people complain of heartburn, indigestion, and ‘stomach upset’, more people will be in the market for over the counter treatments like antacids. This is evident in the urban workers who had altered their lifestyle leading to various strains which affected their health. Further, the rising incidence of aging people who are vulnerable to various digestion related disorders advanced the market since the elderly will always look for products and services that they can afford to use to solve their digestion problems.Increasing awareness and accessibility
As the awareness of the options for antacids and their benefits spreads, the market for them is growing. Concerning the public knowledge and availability of health information on the internet and social media, the population is receiving better information on managing simple diarrhea using OTC drugs. Sales and marketing of these products’ consumer goods are also assisted by pharmacies and retail stores so that these products may reach the consumer. Moreover, the growth of the electronic market places made the access to the antacids easier for the consumers which improved the accessibility of the product. As individuals gain a better and enhanced understanding of what antacids are and where they can get them, a lot of people would utilize them for acid-related symptoms; therefore, the market balloons in size very quickly.Advancements in Antacid Formulations
New developments in the preparation of antacid has played most of the vital role in the growth of the market. Today’s antacids are available in tablets, liquids, chewable forms and gels to a fit the consumer’s taste as well as requirements. New types, like sugar-free, flavoured and the ones that dissolve quickly also increase its appeal to more people which makes antacids a better product. Creating combination products with other useful active substances, such as simethicone for regulated intestinal gas, gives better solutions for the problems with gastrointestinal tracts. They enhance the efficiency and usability of antacids and increase its popularity among the consumers which contributes to market development.Lifestyle Changes and Dietary Habits
Increased awareness and consciousness among the people about the excessive use of antacids can be another factor, which is also demanding new and improved products or brands of antacids in the global market. Intake of processed foods and high fat diets and products, caffeine and alcohol contribute a lot to heart burn and other cases of indigestion. These complications are aggravated by busy schedules and stress hence the need for quick and efficient remedy solutions. Because of the immediate action of antacids and ease of access, people consider them as a perfect remedy for solving their digestive problems. This trend is especially seen in the more developed economy countries where the populations are often under lots of pressure with their busy daily schedules and harsh working conditions as well as indulging themselves with lots of fatty foods frequency, and therefore, the ever-rising market for antacids.Asia Pacific Antacids Market
The Asia Pacific antacids market is growing because of the rising prevalence of GID linked with lifestyle factors and food preferences. From these causes of the digestion problem, one may infer that quick growth of urban centers, fast foods consumption, and pressure have played crucial roles in provoking acid reflux and indigestion. In the same regard, increased consumer knowledge on the availability of OTC medications and ease of access to healthcare facilities contributes to the market’s growth. Major contributors include China, India and Japan due to the large population of patients as well as growing health industries. Variety of ways has been manufactured to reach out to customers through tablets, liquids and chewable help propel the antacid market. Thus, anticipating the further development of the economy, it is pertinent to note that the Asia Pacific region will experience constant growth in the demand for antacids.Worldwide Antacids Company Analysis
The Antacids market is dominated by key players such as Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Company Limited.Antacids Company News
In March 2024, ENO, previously owned by GSK Consumer Healthcare and now part of Haleon, introduced a new product called ENO Chewy Bites, chewable antacids available in Tangy Lemon and Zesty Orange flavors. This expansion offers customers more options for managing stomach discomfort.In March 2023, WonderbellyTM, a company specializing in clean ingredients and medications for digestive health, introduced its Wonderbelly AntacidTM chewable tablets.
Drug Class - Global Antacids Market in 4 Viewpoints :
1. Proton Pump Inhibitors2. H2 Antagonist
3. Acid Neutralizers
4. Pro-Motility Agents
Formulation Type - Global Antacids Market in 4 Viewpoints :
1. Tablets2. Liquid
3. Powder
4. Others
Distribution Channel - Global Antacids Market in 3 Viewpoints :
1. Retail Pharmacy2. Hospital Pharmacy
3. Online Pharmacy
Geography - Global Antacids Market
North America
1. United States2. Canada
Europe
1. France2. Germany
3. Italy
4. Spain
5. United Kingdom
6. Belgium
7. Netherlands
8. Turkey
Asia Pacific
1. China2. Japan
3. India
4. Australia
5. South Korea
6. Thailand
7. Malaysia
8. Indonesia
9. New Zealand
Latin America
1. Brazil2. Mexico
3. Argentina
Middle East & Africa
1. South Africa2. Saudi Arabia
3. United Arab Emirates
Company Insights:
- Overviews
- Recent Developments
- Revenue
Company Analysis:
1. Abbott Laboratories2. AstraZeneca plc
3. Bayer AG
4. Boehringer Ingelheim International GmbH
5. Dr. Reddy’s Laboratories Ltd.
6. GlaxoSmithKline plc
7. Johnson & Johnson
8. Pfizer Inc.
9. Procter & Gamble Company
10. Sanofi S.A.
11. Sun Pharmaceutical Industries Ltd.
12. Takeda Pharmaceutical Company Limited
Table of Contents
1. Introduction2. Research Methodology3. Executive Summary5. Global Antacids Market
4. Market Dynamics
6. Market Share
7. Drug Class
8. Formulation Type
9. Distribution Channel
10. By Country - Global Antacids Market
11. Porter’s Five Analysis
12. SWOT Analysis
13. Company Analysis
Companies Mentioned
- Abbott Laboratories
- AstraZeneca plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- Reddy’s Laboratories Ltd.
- GlaxoSmithKline plc
- Johnson & Johnson
- Pfizer Inc.
- Procter & Gamble Company
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 210 |
| Published | July 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 6.88 Billion |
| Forecasted Market Value ( USD | $ 9.7 Billion |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
